Robin Edwards

3.4k total citations · 1 hit paper
25 papers, 1.1k citations indexed

About

Robin Edwards is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Robin Edwards has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Robin Edwards's work include Cancer Immunotherapy and Biomarkers (12 papers), Radiomics and Machine Learning in Medical Imaging (5 papers) and Immunotherapy and Immune Responses (5 papers). Robin Edwards is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Radiomics and Machine Learning in Medical Imaging (5 papers) and Immunotherapy and Immune Responses (5 papers). Robin Edwards collaborates with scholars based in United States and Sweden. Robin Edwards's co-authors include Michael Montalto, Vipul Baxi, Saurabh Saha, Frederic G. Barr, Jeannette Bennicelli, Meenhard Herlyn, Katherine L. Nathanson, Patricia Brafford, Lianjun Chen and Géza Ács and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Robin Edwards

25 papers receiving 1.1k citations

Hit Papers

Digital pathology and artificial intelligence in translat... 2021 2026 2022 2024 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Digital pathology and artificial intelligence in translational medicine and clinical practice
    2021 314 citations Vipul Baxi, Robin Edwards et al. Modern Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Edwards United States 12 493 492 220 219 205 25 1.1k
Michael Bockmayr Germany 21 394 0.8× 649 1.3× 280 1.3× 278 1.3× 170 0.8× 35 1.4k
Hanne A. Askautrud Norway 12 317 0.6× 563 1.1× 136 0.6× 227 1.0× 346 1.7× 22 1.3k
Bing Ren United States 12 833 1.7× 709 1.4× 181 0.8× 201 0.9× 167 0.8× 26 1.5k
Hui Zeng China 17 397 0.8× 357 0.7× 168 0.8× 125 0.6× 157 0.8× 61 1.1k
Jan H. Rüschoff Switzerland 21 499 1.0× 339 0.7× 654 3.0× 261 1.2× 355 1.7× 51 1.4k
Balázs Ács Sweden 17 230 0.5× 563 1.1× 167 0.8× 333 1.5× 461 2.2× 50 1.2k
Olga Kondrashova Australia 11 339 0.7× 210 0.4× 148 0.7× 158 0.7× 239 1.2× 33 883
Philipp Jurmeister Germany 17 268 0.5× 291 0.6× 239 1.1× 204 0.9× 150 0.7× 45 781
Rachel L. Stewart United States 15 384 0.8× 342 0.7× 157 0.7× 281 1.3× 111 0.5× 31 942
Farah Khalil United States 15 315 0.6× 663 1.3× 214 1.0× 144 0.7× 143 0.7× 37 1.3k

Countries citing papers authored by Robin Edwards

Since Specialization
Citations

This map shows the geographic impact of Robin Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Edwards more than expected).

Fields of papers citing papers by Robin Edwards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Edwards. The network helps show where Robin Edwards may publish in the future.

Co-authorship network of co-authors of Robin Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Edwards. A scholar is included among the top collaborators of Robin Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Edwards. Robin Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szabó, Péter M., Amir Vajdi, Namit Kumar, et al.. (2023). Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment. Scientific Reports. 13(1). 3051–3051. 36 indexed citations
2.
3.
Baxi, Vipul, Robin Edwards, Michael Montalto, & Saurabh Saha. (2021). Digital pathology and artificial intelligence in translational medicine and clinical practice. Modern Pathology. 35(1). 23–32. 314 indexed citations breakdown →
4.
Lee, George, Keyur Desai, Hao Tang, et al.. (2021). 387 The utility of AI-powered spatial classification of intratumoral CD8+ immune-cell distribution in predicting overall survival in patients with melanoma as part of the checkMate 067 clinical trial. Journal for ImmunoTherapy of Cancer. 9(Suppl 2). A420–A420. 2 indexed citations
5.
Szabó, Péter M., Saumya Pant, Scott Ely, et al.. (2021). Development and Performance of a CD8 Gene Signature for Characterizing Inflammation in the Tumor Microenvironment across Multiple Tumor Types. Journal of Molecular Diagnostics. 23(9). 1159–1173. 7 indexed citations
6.
Stein, Julie E., Abhishek Soni, Ludmila Danilova, et al.. (2019). Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response. Annals of Oncology. 30(4). 589–596. 35 indexed citations
7.
Montalto, Michael & Robin Edwards. (2019). And They Said It Couldn't Be Done: Predicting Known Driver Mutations From H&E Slides. Journal of Pathology Informatics. 10(1). 17–17. 9 indexed citations
8.
9.
Szabó, Péter M., George Lee, Scott Ely, et al.. (2019). CD8+ T cells in tumor parenchyma and stroma by image analysis (IA) and gene expression profiling (GEP): Potential biomarkers for immuno-oncology (I-O) therapy.. Journal of Clinical Oncology. 37(15_suppl). 2594–2594. 4 indexed citations
10.
Szabó, Péter M., Zhenhao Qi, Kim E. Zerba, et al.. (2019). Association of an inflammatory gene signature with CD8 expression by immunohistochemistry (IHC) in multiple tumor types.. Journal of Clinical Oncology. 37(15_suppl). 2593–2593. 2 indexed citations
11.
Luke, Jason J., Robin Edwards, Cyrus V. Hedvat, et al.. (2018). Characterization of the immune tumor microenvironment (TME) to inform personalized medicine with immuno-oncology (IO) combinations. Annals of Oncology. 29. viii403–viii403. 2 indexed citations
12.
Luke, Jason J., Nilofer S. Azad, Robin Edwards, et al.. (2018). Phase 1, open-label, adaptive biomarker trial that informs the evolution of combination immuno-oncology (IO) therapies (ADVISE), a precision IO approach to personalized medicine.. Journal of Clinical Oncology. 36(15_suppl). TPS3101–TPS3101. 3 indexed citations
13.
Sepulveda, Antonia R., Dan Jones, Shuji Ogino, et al.. (2009). CpG Methylation Analysis—Current Status of Clinical Assays and Potential Applications in Molecular Diagnostics. Journal of Molecular Diagnostics. 11(4). 266–278. 39 indexed citations
14.
Sepulveda, Antonia R., Dan Jones, Shuji Ogino, et al.. (2009). A Report of the Association for Molecular Pathology. 3 indexed citations
15.
Smalley, Keiran S.M., Rooha Contractor, Thiennga K. Nguyen, et al.. (2008). Identification of a Novel Subgroup of Melanomas with KIT/Cyclin-Dependent Kinase-4 Overexpression. Cancer Research. 68(14). 5743–5752. 82 indexed citations
16.
Coughlin, Christina, Marisa Dolled‐Filhart, Charles Zacharchuk, et al.. (2008). Src pathway activation correlates with treatment resistance in breast cancer and identifies patient subsets predicted to benefit from Src inhibition. Clinical Cancer Research. 14. 1 indexed citations
17.
Spittle, Cynthia, Maria R. Ward, Katherine L. Nathanson, et al.. (2007). Application of a BRAF Pyrosequencing Assay for Mutation Detection and Copy Number Analysis in Malignant Melanoma. Journal of Molecular Diagnostics. 9(4). 464–471. 87 indexed citations
18.
Edwards, Robin, et al.. (2004). Absence of BRAF mutations in UV-protected mucosal melanomas. Journal of Medical Genetics. 41(4). 270–272. 134 indexed citations
19.
Edwards, Robin, et al.. (1997). Detection of Gene Fusions in Rhabdomyosarcoma by Reverse Transcriptase-Polymerase Chain Reaction Assay of Archival Samples. Diagnostic Molecular Pathology. 6(2). 91–97. 40 indexed citations
20.
Edwards, Robin, et al.. (1997). Detection of Gene Fusions in Rhabdomyosarcoma by Reverse Transcriptase-Polymerase Chain Reaction Assay of Archival Samples. Diagnostic Molecular Pathology. 6(3). 177–177. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Bockmayr Breakdown of academic impact, for papers by Hanne A. Askautrud Breakdown of academic impact, for papers by Bing Ren Breakdown of academic impact, for papers by Hui Zeng Breakdown of academic impact, for papers by Jan H. Rüschoff Breakdown of academic impact, for papers by Balázs Ács Breakdown of academic impact, for papers by Olga Kondrashova Breakdown of academic impact, for papers by Philipp Jurmeister Breakdown of academic impact, for papers by Rachel L. Stewart Breakdown of academic impact, for papers by Farah Khalil
Rankless by CCL
2026